See inside every stock. Pro
S&P 5007,624▼ 0.52%Nasdaq25,955▼ 0.21%Dow Jones52,215▼ 1.23%Nasdaq 10028,958▼ 0.00%VIX19.45▲ 2.21%US Dollar101.75▲ 0.14%Gold spot4,012▼ 0.30%WTI103.44▲ 3.99%
← 0QJS page
XStocksXray
Market X-Ray report · 23 October 2026

Clariant AG (0QJS)

London Exchange · UK · prices in GBP · close of 23 Oct 2026

Key indicators

Last closeGBP 9.943
52-week range6.555 – 11.030
Return, 1 month / 3 months−6.4% / +37.8%
Return, 1 year / 3 years+37.8% / −19.9%
TrendAbove 200-day, below 50-day
RSI (14)34
Volatility (1 year)34.6%
Worst drawdown (1 year)-20.2%
Average daily value traded3.53M GBP
Dividend yield–

Market X-Ray price-based

76/ 100 · High confidence · ahead of 95% of stocks on this exchange
Trend84
Momentum88
Stability (higher is calmer)62
Liquidity65
Income–

Five-year price chart navy: price · brown: 200-day average

5.839.6513.4817.3021.122021-102023-012024-042025-072026-10

About the company

Clariant AG is a specialty chemicals company based in Switzerland. It makes additives, catalysts, pigments and masterbatches, along with other specialty chemical products. Its customers are manufacturers in industries such as plastics, coatings, automotive, textiles and consumer care, who use these materials to improve the performance and appearance of their own products. The company serves industrial markets in many countries around the world.

Clariant AG trades under the code 0QJS on the London Exchange in UK, with its price quoted in pounds sterling (GBP). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Clariant AG (0QJS) trades on the London Exchange in UK. It last closed at GBP 9.943 on 23 October 2026.

Its price-based Market X-Ray is 76 out of 100 (a strong price profile), ranking 204 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price rose 37.8% and over the last three months it rose 37.8%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Clariant AG (0QJS)

The five lenses in numbers each metric is ranked against the other stocks on London Exchange

Lens and metricValueScoreReading
Trend84 · StrongTrading above its long-term averages and near its highs.
Above 200-day average17.0%
From 52-week high-9.0%
Momentum88 · StrongRising faster than most stocks on this exchange.
3-month return37.8%
6-month return22.7%
12-month return, skipping the last month47.3%
Stability (higher is calmer)62 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)34.6%
Worst drawdown, 1 year (smaller is calmer)-20.2%
Liquidity65 · FairModerate trading activity.
Average daily value traded3.53M GBP
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends5

Strengths

  • Trend: Trading above its long-term averages and near its highs.
  • Momentum: Rising faster than most stocks on this exchange.

Weak spots

No lens is weak against its exchange.

Returns

1 week−6.9%
1 month−6.4%
3 months+37.8%
6 months+22.7%
1 year+37.8%
3 years−19.9%
5 years−44.4%

Signals

50-day / 200-day average10.537 / 8.499
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.222

Technical summary

DailyNeutral7 bullish · 1 neutral · 8 bearish
WeeklyBullish8 bullish · 1 neutral · 3 bearish
MonthlyBullish5 bullish · 1 neutral · 2 bearish

Recent dividends

Ex-dividend dateAmount per share
2 Jun 2026GBX 0.0042
2 Jun 2025GBX 0.0042
30 May 2024GBX 0.0042
2 Jun 2023GBX 0.0042
8 Sep 2022GBX 0.0040
30 Jun 2021GBX 0.0070

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 24 Oct 2026